ResearchGate
LinkedIn
Academic & publication writing
Manuscripts, evidence synthesis, literature reviews, theses, publication strategy, and journal-ready scientific narratives.
Founder & Director · Anchoris Pharma Limited
Dr Marjan
Gholghasemi
Pharm.D. · Pharmaceutical Scientist · Medical Writer
Connecting rigorous pharmaceutical science with clear, credible communication for academic, medical affairs, and regulatory audiences.
Professional profiles
Research, identity, and professional network.
Verified direct profiles are labelled clearly. Scholar and ORCID remain discovery links until their unique public profile IDs are confirmed.
Professional profile
Evidence deserves language that is accurate, useful, and human.
“My work begins with the science and ends with the reader: what they need to understand, decide, or do next.”
Dr Marjan Gholghasemi is a Pharm.D.-trained pharmaceutical scientist, medical writer, and Founder & Director of Anchoris Pharma Limited. Her work brings together evidence appraisal, scientific precision, and audience-aware communication.
Her research interests span molecular neuroscience, neuropharmacology, neurodegeneration, pharmaceutical analysis, and evidence synthesis. Across academic, commercial, and regulatory settings, she focuses on transforming complex source material into writing that remains traceable, proportionate, and genuinely useful.
- Current role
- Founder & Director, Anchoris Pharma Limited
- Professional foundation
- Doctor of Pharmacy (Pharm.D.)
- Core practice
- Medical writing, medical affairs, evidence synthesis
- Research lens
- Neuroscience, pharmacology, pharmaceutical analysis
Areas of practice
One scientific standard, across every audience.
Medical affairs communication
Evidence-led content for healthcare professionals, advisory boards, scientific exchange, and medical education.
Regulatory & clinical documents
Structured, traceable documents designed around source integrity, review readiness, and compliance-aware workflows.
Selected scholarly work
Research across neuroscience, clinical evidence, and pharmaceutical analysis.
CEDNIK Syndrome
A scholarly contribution within rare disease and neurological literature.
ResearchGateTLIF versus PLIF: radiological and clinical outcomes
Comparative evidence synthesis across spinal fusion approaches and patient outcomes.
ResearchGateEarly palliative care in advanced-stage Alzheimer’s disease
Quality-of-life and psychological considerations in advanced neurodegenerative disease.
ResearchGatePrediction of ropinirole urine level using ANFIS
Pharmaceutical analysis combining analytical methods with adaptive modelling.
ResearchGateThe pharmacy journal
Notes for curious, evidence-minded readers.
Independent reflections by Dr Marjan on how we understand medicines and communicate the evidence around them.
3 articles
Pharmacology
From mechanism to meaning: what makes a medicine clinically relevant?
A mechanism can be elegant without being decisive. The more important question is what it means for a defined patient population, at a defined dose, against a meaningful comparator.
5 min readRead note
Evidence
Five questions I ask when reading a clinical paper
A practical framework for moving past the abstract and asking who was studied, what was compared, what changed, and how certain we can be.
6 min readRead note
Medical writing
Why good medical writing preserves uncertainty
Clear writing should reduce confusion, not manufacture certainty. A note on confidence, qualifiers, and keeping conclusions proportionate to evidence.
4 min readRead note
No articles match that search yet.